D.R. Horton (NYSE:DHI) Given Neutral Rating at Wedbush : vim

D.R. Horton (NYSE:DHI – Get Free Report)‘s stock had its “neutral” rating reaffirmed by equities researchers at Wedbush in a research report issued to clients and investors on Tuesday, Benzinga reports. They currently have a $115.00 price objective on the construction company’s stock. Wedbush’s price target points to a potential downside of 27.08% from the […]

Related Keywords

United States , Raymond James , Barbarak Allen , Aronm Odom , Mascoma Wealth Management , Wells Fargo Company , Dr Horton Inc , Goldman Sachs Group , Newton One Investments , Fairfield Bush , Bluepath Capital Management , Securities Exchange Commission , Barclays , Get Free Report , Exchange Commission , Director Barbara , Street Markets , Wealth Management , Path Capital Management , South Central , Dr Horton , Nyse Dhi , Dhi , Construction , 23331a10 , Reiterated Rating , Wedbush ,